Biotech

All Articles

Bicara, Zenas seek IPOs to press late-phase resources towards market

.Bicara Rehabs as well as Zenas Biopharma have given clean motivation to the IPO market along with f...

Genentech to finalize cancer immunology research department

.Genentech will definitely close its cancer immunology research team, and system mind and well-known...

Kezar loses sound cyst however to prove its really worth in stage 1 trial

.Kezar Life Sciences is falling its own dim stage 1 sound growth drug as the biotech goes all-in on ...

Acelyrin loses izokibep, lays off 3rd of staff

.Even with izokibep maintaining its newfound winning streak in the medical clinic, Acelyrin is actua...

Rivus' period 2 obesity-related cardiac arrest trial reaches endpoint

.Rivus Pharmaceuticals has plumped up the customers of its fat-busting, muscle-sparing drug applican...

Ovid halts preclinical job, IV program after soticlestat neglect

.Ovid Therapy currently disclosed final month that it was actually trimming its own head count as th...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Seaport

.Eli Lilly has actually opened up a $700 million R&ampD facility in the Boston ma Seaport, enhancing...

Boundless Bio produces 'modest' layoffs five months after $100M IPO

.Simply 5 months after protecting a $100 thousand IPO, Limitless Bio is actually actually giving up ...

Halda's $126M will definitely evolve 'hold and also kill' growth drugs

.The initial stages of oncology R&ampD aren't short of appealing brand-new methods, and also Halda T...

Lykos 'remorses' certainly not revealing research transgressions with publisher

.Psychopharmacology has pulled 3 posts about midstage clinical test data evaluating Lykos Therapies'...